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Abstract
Background: To date several studies have sought to catalog the full suite of antibodies that
humans naturally produce against single antigens or other specificities (repertoire). Here we
analyze the properties of all sequenced repertoires in order to better understand the specificity of
antibody responses. Specifically, we ask whether the large-scale sequencing of antibody repertoires
might provide a diagnostic tool for detecting antigen exposure. We do this by examining the
overlap in VH-, D-, and JH- segment usage among sequenced repertoires.
Results: We find that repertoire overlap in VH-, D-, and JH-segment use is least for VH segments
and greatest for JH segments, consistent with there being more VH than JH segments in the human
genome. We find that for any two antigens chosen at random, chances are 90 percent that their
repertoires' VH segments will overlap by less than half, and 98 percent that their VDJH combinations
will overlap by ≤10 percent. We ran computer simulations to test whether enrichment for specific
VDJH combinations could be detected in "antigen-exposed" populations, and found that enrichment
is detectable with moderate-to-high sensitivity and high specificity, even when some VDJH
combinations are not represented at all in some test sets.
Conclusion: Thus, as large-scale sequencing becomes cost-effective for clinical testing, we suggest
that sequencing an individual's expressed antibody repertoire has the potential to become a useful
diagnostic modality.
Background
The antigen-binding variable regions of antibody mole-
cules draw combinatorially from a set of somatically
encoded V, D, and J gene segments [1]. Mathematically,
this strategy allows for ~6,000 possible heavy chain (sub-
script H) and ~300 possible light chain (subscript L) V(D)J
combinations, for a total of ~1.8 million possible heavy-
and-light chain pairings [2,3].
Much work in immunology and structural biology has
gone into studying how antibody sequence and structure
affect antigen specificity [1]. In each antibody, contact
with the antigen is made by six short regions, three on
each heavy and light chain. These are known as the com-
plementarity-determining regions (CDRs). CDR1 and
CDR2 lie entirely within the V segment, while CDR3
spans the D segment and flanking parts of V and J (in
heavy chain; in light chain, which lacks a D segment,
CDR3 spans the V-J junction). In general, heavy chain
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contributes more than light chain to antigen binding and
specificity, and CDR3 contributes more than CDR1 and
CDR2 [4]. Hence heavy chain VDJ (VDJH) segment usage
is a major determinant of antigen specificity.
There are other determinants. The part of an antigen that
an antibody binds is called an epitope; the part of an anti-
body that an epitope binds is called a paratope. Single
antigens may have multiple epitopes, and single antibod-
ies may have multiple paratopes [5,6]. Moreover, non-
templated nucleotide insertions and deletions at gene
segment junctions, together with CDR hypermutation,
expand antibody diversity and antigen binding possibili-
ties far beyond what is available through V(D)J combina-
torics alone [1]. Hence V(D)J segment choice and
sequence-level modification provide coarse- and fine-tun-
ing, respectively, for antigen specificity, but different
V(D)J and sequence combinations may well bind the
same antigen.
These considerations and substantial experimental data
(summarized in [4]) argue against a strict one-to-one rela-
tionship between antibody sequence and antigen specifi-
city. However, they do suggest the possibility that antigens
may have signature antibody repertoires. Here a repertoire
is defined as a set of antibodies, defined by gene segment
usage, that is produced in a population of people against
a given specificity. A specificity comprises a single epitope,
a set of epitopes on a single antigen, or a set of antigens.
To date several studies have addressed this idea in partic-
ular instances by sequencing antibodies specific for partic-
ular antigens. In one such study, circulating B cells from
seven infants vaccinated against Hemophilus influenzae
type b (Hib) were affinity enriched aganst Hib capsular
polysaccharide (PS); rearranged V(D)J heavy and light
chain gene libraries were then constructed and screened
for Hib PS-specific antibodies [7]. The antibodies recov-
ered all used the same VH segment (VH3–23) and only two
JH and two VL and JL segments, consistent with previous
studies [8,9]. This is consistent with the pattern seen in
natural antibody populations, allowing consideration of
data from this in vitro "scrambling" approach.
Repertoires against other antigens have also been shown
to have restricted segment usage, although the degree and
pattern of restriction vary. For example, using a technique
similar to that described for Hib PS, the repertoire against
Streptococcus pneumoniae serotype 23F PS was found to be
dominated by four VH segments, which account for 90
percent of the repertoire's observed VH diversity; four JH
segments (93% of JH diversity); and two VL-kappa seg-
ments (93%) [10]. For comparison, the repertoire against
S. pneumoniae serotype 6B PS was found to be dominated
by three VH segments (93%) and three JH segments (98%),
but was found to lack strong VL-kappa restriction (90% in
six segments) [11]. Association patterns among segments
and chains were also found to vary.
In all, repertoires for over a dozen antigens have been
studied individually, with various aims and to various
extents, mainly through enrichment and cloning or
through screening of phage-display libraries [7,10-14].
The aim of the present study is to analyze these repertoires
as a group in order to better understand the specificity of
antibody responses. The practical goal is to explore the
possibility that in the future, large-scale sequencing of
antibodies in an individual may be used as a fingerprint,
or "pan-scan," of that person's antigen exposure.
Results
We analyzed VDJH segment usage for the 16 best-repre-
sented natural human repertoires in the IMGT database
(see Methods). These comprised 292 antibody sequences
(mean, 18 sequences per repertoire; range, 8–41). Six rep-
ertoires were directed against infectious agents, while 10
were directed against autoimmune agents (Table 1 and
Additional File 1).
Gene segment usage patterns
Genome-level diversity was well represented among the
repertoires as a group. All but one (VH7) of the VH and D
gene segment families were represented, and the majority
of individual VH (78%), D (91%), and JH (100%) gene
segments appeared in at least one sequence. VH and D
gene families were represented about as often as in a pre-
vious study of healthy individuals [15] (p = 0.01 and 0.13,
R2 = 0.78 and 0.96 for VH and D families, respectively), as
were individual JH gene segments (p = 0.004, R2 = 0.94).
However, individual VH gene segments were used more
variably (p = 0.90, R2 = 0.25).
These observations are consistent with there being more
than one VDJH combination used in antibodies with a
given specificity (see below). They also suggest either that
our set of repertoires is a good representation of at least
the kinds [16] of antigen or antigen patterns encountered
naturally, or conversely that B cell populations of the
healthy individuals sampled in the previous study [15]
comprise clones expanded against specificities similar to
the ones included in our present analysis. These possibil-
ities are not mutually exclusive.
Figure 1 shows VH, D, and JH segment usage and VDJH
combination usage patterns for the repertoires of repre-
sentative specificities. Some repertoires were peaked and
narrow, suggesting few epitopes or immunodominance
among the epitopes in their specificities, or little diversity
among individuals for these specificities ("public" or
"semi-public" repertoires; see Discussion). OtherBMC Genomics 2005, 6:148 http://www.biomedcentral.com/1471-2164/6/148
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repertoires were flat and broad, suggesting many epitopes
or codominance among the epitopes in their specificities,
or greater diversity among individuals for these specifici-
ties. Details of VH, D, and JH segment usage for particular
specificities have been discussed elsewhere (see references
for specific sequences in IMGT, Table 1, and Additional
File 1).
The data did not allow conclusive generalization about
whether or not, for a given repertoire, VH, D, and JH seg-
ments are combined randomly or with some bias. This is
because the number of antibodies sequenced in a given
repertoire was small (8–41 sequences) relative to the
number of VDJH combinations that could in principle be
constructed from the VH, D, and JH  segments that
appeared in that repertoire (~50–1,000 possibilities).
For only one of the 16 repertoires – the repertoire for thy-
roid peroxidase – was there a tight, statistically significant
correlation between the observed frequencies of VDJH
combinations and the frequencies that would be expected
if segments were combined at random (p < 0.01; R2 =
0.85). The repertoire for S. pneumoniae strain 6B polysac-
charide also showed a tight correlation, but this correla-
tion fell short of statistical significance (p = 0.10; R2 =
0.95). No tight, statistically significant correlation was
observed for any other repertoire. These findings are con-
sistent with the conclusion that VH, D, and JH segments are
not joined at random in at least 14 of these 16 repertoires,
but more sequencing is needed to settle this issue.
Overlap in gene segment usage
From a practical perspective, for repertoires to serve as sig-
natures for particular specificities, the overlap in gene seg-
ments or in V(D)J combinations among different
repertoires must be low. To estimate this overlap quanti-
tatively, we calculated the percent overlap between each
pair of specificities in the data set (Fig. 2).
We found that for any two specificities picked at random
from our set, the probability was 90 percent that their rep-
ertoires' VH gene segment usage overlapped by half or less
(Fig. 2a, red tones). Adding D and JH segment information
decreased the overlap markedly: of the 240 pairwise com-
parisons between different specificities in our data set,
only four (1.7%) showed more than 10 percent overlap:
between dsDNA and RhD (12%), thyroid peroxidase
(TPO) and factor VIII (16%), TPO and phospholipid
(11%), and phospholipid and integrin gpIIb/IIIa (11%) –
all autoimmune specificities. Although not random in
segment usage, autoimmune antibodies may share com-
mon features that result from impaired negative selection.
Overall, for any two specificities chosen at random, the
probability was 98.3 percent that their repertoires' VDJH
combinations overlapped by 10 percent or less (Fig. 2b).
Given the large number of possible VDJH combinations
(~6,000) and the relatively small size of the data set (292
sequences), it is reasonable to ask whether or not such a
small amount of overlap is likely to occur by chance.
Probability calculations show that it is not. The two most
Table 1: Repertoire composition
specificity sequences VH genes D genes JH genes VDJH combos
E. histolytica 97527
HBsAg (HBV) 12 9 8 3 11
PS (S. pneumo 2 3 F ) 2 371 041 5
gp120 (HIV) 26 10 16 6 24
PS (S. pneumo 6 B ) 4 151 031 1
d s D N A  ( h u m a n ) 87648
M A G  ( h u m a n ) 97749
P L  ( h u m a n ) 98849
Fab (human) 11 9 7 3 10
f a c t o r  V I I I  ( h u m a n ) 1 9 3536
cardiolipin (human) 12 7 7 3 10
gpIIb/IIIa (human) 14 12 10 3 14
myosin (human) 14 12 10 5 14
RhD (human) 22 9 14 5 20
D N A  ( h u m a n ) 2 2 1 2 1 342 0
TPO (human) 41 6 11 4 16
total 292 36 21 6 192
Number of sequences, gene segments, and gene segment combinations in the repertoires of all specificities in the data set. Specificities associated 
with infectious agents listed first; species names within parentheses (where necessary). Abbreviations: E. histolytica, Entameba histolytica; HBV, 
hepatitis B virus; PS, polysaccharide; S. pneumo, Streptococcus pneumoniae; ds, double-stranded; MAG, myelin-associated glycoprotein; PL, 
phospholipid; TPO, thyroid peroxidase.BMC Genomics 2005, 6:148 http://www.biomedcentral.com/1471-2164/6/148
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Gene segment use for representative repertoires Figure 1
Gene segment use for representative repertoires. Repertoires for three specificities are shown: human coagulation fac-
tor VIII, Streptococcus pneumoniae serotype 6B capsular polysaccharide (PS), and S. pneumoniae ser. 23F PS. Each histogram 
shows the frequency distribution of VH gene segments, D segments, JH segments, and VDJH combinations. More peaked distri-
butions indicate that the repertoire is VH, D, JH, or VDJH restricted. For example, the S. pneumoniae ser. 6B repertoire is 80% 
restricted to JH gene segment JH4.BMC Genomics 2005, 6:148 http://www.biomedcentral.com/1471-2164/6/148
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common human haplotypes allow a maximum of 5,244
and 6,348 possible functional VDJH  combinations,
respectively; the probability that the small amount of
overlap observed in our data should arise by chance is p =
0.004 (0.4%) and 0.011 (1.1%) for these two haplotypes,
respectively (see Methods). Note that nonrandom associ-
ation among VH, D, and JH segments means that only a
fraction of these 5,244 or 6,348 possible combinations
are actually observed. The smaller the number of combi-
nations, the higher the probability that repertoires will
overlap by chance. Hence the small amount of overlap
observed in the data is even less likely to be the result of
chance than these calculations suggest. The probabilities
are therefore upper limits.
If the specificities analyzed in this study are indeed repre-
sentative of the specificities to which human beings are
exposed (see above), this finding suggests that VDJH-
defined sequences may be able to distinguish dependably
among a wide variety of specificities.
Simulating detection
For repertoires to be of practical use, it must be possible to
detect when certain VDJH combinations are present at a
higher-than-background frequency. This may indicate, for
example, prior or ongoing exposure to an infectious agent
or the presence of a response to a vaccine [17]. Ideally
detection should be possible even when this frequency is
barely above background – that is, when the signal-to-
noise ratio is low.
To test whether enrichment might be detectable, we ran
computer simulations for each specificity. These were
done briefly as follows (for details, see Methods). For each
specificity, we assembled several sets of sequences that
were each enriched for sequences of that specificity's rep-
ertoire. (The analogy is that each set of sequences corre-
sponds to what might be obtained from a blood sample
of an individual known to have a clinical history of that
specificity.) The collection of these sets was our "reference
collection" for the test (medically, the gold standard). The
strategy was to see if test sets could be assigned as exposed
or unexposed by comparing their patterns of VDJH combi-
nations to the ones from the reference collection. If anti-
bodies in a test set had a similar pattern and prevalence of
VDJH combinations as those in the reference collection,
the test set was assigned as "exposed." If the patterns were
dissimilar, the test set was assigned as "unexposed."
Assignment was performed with the aid of a computer-
ized algorithm (see Methods).
We tested this approach for each specificity by seeing how
well exposed and unexposed sets could be assigned. In
clinical infections, B cells specific for an infectious agent
rarely exceed 5–10 percent of the total B cell population.
Overlap in segment use among repertoires Figure 2
Overlap in segment use among repertoires. Overlap in 
(a) VH gene segment and (b) VDJH use among all repertoires. 
The percent overlap is grayscale-coded according to the key 
below each plot. In (b), the range at the lower end of the 
scale is expanded in order to show the four pairs with 11–20 
percent overlap (see text). Abbreviations: ds-DNA, double-
stranded DNA; gp120, HIV-1 gp120; Sp, Streptococcus pneu-
moniae serotype; fVIII, clotting factor VIII; HBsAg, HBV sur-
face antigen; IIb/IIIa, glycoprotein IIb/IIIa; MAG, myelin-
associated glycoprotein; PL, phospholipid; TPO, thyroid per-
oxidase. Species of origin are as in Table 1.BMC Genomics 2005, 6:148 http://www.biomedcentral.com/1471-2164/6/148
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Therefore, as a conservative test, the sets in the reference
collection had only 1–2.5 percent of their VDJH combina-
tions purposely drawn from the repertoire for the given
specificity. For example, in testing for exposure to HIV
gp120, of 1,000 VDJH combinations determined for a set
in the reference collection, only 10–25 would be guaran-
teed to be combinations that appeared in the HIV gp120
repertoire; the rest would be from the repertoires of S.
pneumoniae serotype 6B PS, double-stranded (ds) DNA,
and the other 14 specificities. Note that in this approach
not all combinations are guaranteed to appear in any one
set; however, the more frequently a combination appears
in the repertoire – the higher its prevalence – the more
likely (and more often) it is to appear in a given set. Also,
the larger the reference collection, the more likely that less
prevalent combinations will also appear in at least one set.
A training collection for each specificity was assembled
comprising 10 exposed and 10 unexposed sets. An addi-
tional 50 test sets, whose exposed/unexposed status was
known to us but not to the algorithm, were presented for
assignment. Performance was measured by sensitivity and
specificity (see Methods). Figure 3 shows results for two
typical simulations. Sensitivity generally reached between
0.7 and 0.8 when exposure-specific antibodies/sequences
were five percent of the total; specificity was higher (most
likely due to false negatives in the sensitivity because of
the small size of the reference sets). Sensitivity was
improved by increasing the size of and enrichment in the
sets in the reference collection. (Here the terms "sensitiv-
ity" and "specificity" are used in the epidemiological
sense; see Methods.)
Discussion
The majority of modern clinical tests assay for just one
analyte at a time [18]. They determine the presence or
absence of the analyte, and sometimes its quantity, but
provide no information about other analytes. For exam-
ple, a nucleic acid test for HIV-1 determines whether or
not HIV-1 RNA is present in blood, and how much, but
provides no information about, for example, the presence
of antibodies to CMV. Although such tests are the main-
stay of modern medicine, conceptually, they are limited to
providing a "20 questions," yes-or-no approach to
diagnosis.
The major exception is the standard culture-based method
for diagnosing bacterial infections. In this method, the
first step is to apply a clinical sample to standard culture
media to see what grows [19]. This method is powerful in
that it presupposes little about the identity of the bacteria:
it can distinguish among many bacteria with a single test,
and often reveals the presence of species that were clini-
cally unexpected. Conceptually, this is an open-ended,
"what-is-there" approach to diagnosis. It is of general
interest in medicine to develop more diagnostic tech-
niques that use this approach.
Antibodies play a crucial role in protective immunity and
immunopathology, and also are important in surveillance
against cancer [1]. The relationship between antibody
gene sequence and epitope specificity is complex, but sev-
eral studies have shown that certain gene segments and
gene segment combinations are used preferentially
against specific epitopes, antigens, or sets of antigens –
what we here call "specificities" [7,10-14]. The identity
and frequency of gene segments or combinations define
antibody repertoires.
In this paper we have analyzed the growing, albeit limited,
data that exists on VDJH combination defined repertoires
to see whether they might one day provide an open-ended
diagnostic for antigens to which a person has been
exposed. For statistical confidence, we analyzed only
those specificities for which at least eight antibodies have
been sequenced and annotated for VH, D, and JH gene seg-
ment use. A similar amount of systematic data for immu-
noglobulin light chains and T cell receptors is still
Detection of exposure to representative specificities Figure 3
Detection of exposure to representative specificities. 
Representative plots of sensitivity and specificity for detect-
ing exposure at various levels (f; see Methods for details): (a) 
Streptococcus pneumoniae serotype 6B and (b) S. pneumoniae 
ser. 26F. In general sensitivities reached between 0.7 and 0.8 
when repertoires were enriched to at least 5 percent (f = 
0.05), and specificities reached between 0.95 and 1.BMC Genomics 2005, 6:148 http://www.biomedcentral.com/1471-2164/6/148
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unavailable, and so the present analysis was limited to
immunoglobulin heavy chains.
Our data set represented nearly every gene segment fam-
ily, and at frequencies similar to those seen in two healthy
individuals in a previous study [15]. One interpretation is
that this reflects an intrinsic bias in the frequency with
which different VDJH  combinations are formed or
expressed. Another interpretation is that the specificities
in our data set are representative of the exposures that
shape repertoires in healthy individuals, since certain
types of antigens – bacterial polysaccharides, for instance
– select for certain canonical structures in antibodies, and
segments of the same gene family are more likely to pro-
duce similar structures [16]. These two interpretations are
not mutually exclusive.
The narrowness or breadth of the repertoires for individ-
ual specificities (Fig. 2) could simply reflect the number of
epitopes per specificity. For example, the antibodies
against factor VIII, which formed a narrow repertoire, are
known to have been raised against relatively well defined
domains of factor VIII that comprise few epitopes [20],
while antibodies against dsDNA, which formed a broad
repertoire, were not raised this way [21].
The fact that the same VDJH combinations were recovered
from multiple individuals in many repertoires (e.g., the S.
pneumoniae PS repertoires [10,11]) suggests that despite
genetic differences, different individuals may often use the
same or at least overlapping sets of VDJH combinations in
the antibodies they make against a given epitope. These
could be called "public" or "semi-public" combinations
[7,3]. Such commonalities might shed light on the evolu-
tionary forces – repeat exposure to particular infectious
agents, for example [4] – that may have shaped and main-
tained germline gene segment diversity. Further sequenc-
ing experiments using specificities defined at the epitope
level would be useful to determine how often and to what
epitopes public and semi-public combinations occur. The
more frequent public combinations turn out to be, the
more narrowly defined specificities can be and remain
detectable, and vice versa.
Repertoires' VDJH combinations overlapped rarely (Fig.
3b), and less often than would be predicted by chance (p
≤ 0.011). Specifically, for any two specificities chosen at
random, chances were 98.3 percent that they overlapped
by 10 percent or less. This suggests that determining VDJH
usage for a sampling of antibodies can be used to identify
exposure to a particular antigen or set of antigens with rea-
sonable specificity.
To further explore this idea, we conducted a set of simula-
tion experiments to see whether individuals could one
day be diagnosed as being exposed or not exposed to a
given specificity (relative to a normal baseline) by assay-
ing for enrichment of certain VDJH combinations. We
show that even at modest levels of enrichment, which rep-
resents an increased frequency of B cells specific to a cer-
tain exposure, and using just 10 reference sets as the "gold
standard" for exposure, assignment of unknown sets as
either exposed or unexposed was possible with a high
degree of sensitivity and specificity. In principle, such a
sequence-based method has the advantage of being able
to detect patterns of exposure even when the specificity of
the antibodies or the identity of the offending agent is
completely unknown. This "open-ended" approach is
most useful for the early detection of emerging diseases,
and will become practicable as improvements in sequenc-
ing technology make it possible to use in the clinic [22].
Data on antibody titers and functionality will doubtless
add to the utility of this approach.
Conclusion
In sum, this study is the first to our knowledge that inves-
tigates the relationship between antibody specificity and
VDJH segment usage for a large number of sequenced anti-
bodies. Further sequencing studies should make it possi-
ble to refine the conclusions presented here, and also to
assess the contribution of light chain in antibodies and of
alpha and beta chains in T cell receptors to antigen specif-
icity in human immune responses. Whether or not large-
scale sequencing will prove useful as a future diagnostic
tool will depend on these further studies.
Methods
Antibody repertoire data
The ImMunoGeneTics database (IMGT; http://
imgt.cines.fr/) is a publically available curated online
repository of ~88,000 sequenced immunoglobulin and T
cell receptor genes from a number of species [2]. We
extracted all ~531 entries that contained recombined
human immunoglobulin genes annotated with VH, D,
and JH gene segment use and antigen specificity.
To approximate only natural repertoires, we limited our
analysis to sequences isolated from B cells of individuals,
and excluded all sequences that had been designed or
modified  in vitro. Allowed sequences included ones
obtained from Epstein-Barr Virus (EBV)-immortalized B
cells, through combinatorial cloning or phage-display
libraries constructed from B cells of antigen-exposed
patients, and from single sequenced B cells. For statistical
power we considered only those specificities that had at
least eight sequences in IMGT. There were 16 such specif-
icities, comprising a total of 292 individual antibody
sequences (mean, 18 sequences per specificity; range, 8–
41).BMC Genomics 2005, 6:148 http://www.biomedcentral.com/1471-2164/6/148
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Frequency distributions and overlap
We calculated and tabulated VH, D, and JH frequency dis-
tributions from all specificities and calculated their pair-
wise overlap computationally. Because specificities
generally differed in the number of unique VDJH combi-
nations in their repertoires, overlap was not symmetric:
for example, if one specificity's repertoire comprised five
different VDJH  combinations, and another specificity's
repertoire had those same five combinations as well as an
additional 15, the overlap would be 100 percent in one
direction, but only 25 percent in the other.
Student's t-test for two independent samples was used to
obtain p-values for calculated vs. observed frequencies of
VDJH combinations for each repertoire. Heatmap plots
were made using R http://cran.r-project.org/.
Humans most commonly encode 38 functional VH genes,
23 functional D genes, and 6 functional JH genes, as well
as a number of pseudogenes [2]. These allow for a theoret-
ical maximum of 38 × 23 × 6 = 5,244 possible VDJH com-
binations. In addition, many Caucasians contain a partial
duplication of the VH region that results in 46 functional
VH genes [2]; this partial duplication allows for a theoret-
ical maximum of 46 × 23 × 6 = 6,348 VDJH combinations.
For a person with a maximum of 5,244 possible VDJH
combinations, the probability that two sets of 10 ran-
domly chosen combinations will not overlap at all is
approximately [(5,244 - 10)/5,244]10 = 0.98, or 98 per-
cent. The probability that a third set of, for example, seven
combinations will not overlap at all with either of these
two sets is approximately [(5,244 - 10)/5,244]10 × [(5,244
- 10 - 10)/5,244]7 = 0.96, or 96 percent. The probability of
overlap among any group of sets may be approximated by
extending this method.
Simulations
We built a pattern-detecting computer algorithm for
detecting enrichment of antibody sequences that corre-
spond to particular specificities [23] (single-hidden layer,
feed-forward neural networks with backpropagation;
Brainstem v1.4; http://digforfire.dyndns.org:8847).
For each specificity, the algorithm was trained on a refer-
ence collection representing 10 exposed and 10 unex-
posed sequence sets as follows. Each set constituted a list
of the frequency of each of 100 VDJH combinations drawn
equally from all the specificities in the data set. For each
specificity, we sampled a fraction (f) of combinations
from that specificity's repertoire according to their fre-
quency distribution, allowing resampling. The remainder
were sampled from all sequences in the data set, including
those of the chosen repertoire, again allowing resampling.
This remainder represents a background of noise against
which a signal – enrichment of specific sequences – might
be detected. 0 <f ≤ 1 for exposed sets and f = 0 for unex-
posed sets. Hence, a set is "exposed" if it is statistically
enriched for sequences a particular specificity, and "unex-
posed" otherwise. Note that unexposed sets will contain
some sequences from the chosen exposed repertoire by
chance, just at lower frequency than in exposed sets. Our
question was, how well can we assign, or "diagnose,"
exposure: i.e., how well can we detect enrichment.
The algorithm was used to evaluate test sets, each compris-
ing an additional 25 exposed and 25 unexposed patients.
For each specificity, the algorithm was trained at 0.01 ≤ f
≤ 0.025 (for the exposed patients) and tested over the
range 0.01 ≤ f ≤ 1. To quantify the results, we calculated
the sensitivity [(true positives)/(true positives + false neg-
atives)] and specificity [(true negatives)/(true negatives +
false positives)] of the algorithm for each test set. These
are standard metrics for diagnostic tests in the clinical set-
ting [18].
List of abbreviations
dsDNA, double-stranded DNA; HIV-1, human immuno-
deficiency virus type 1; Sp, Streptococcus pneumoniae sero-
type; fVIII, clotting factor VIII; HBsAg, hepatitis B virus
surface antigen; IIb/IIIa, glycoprotein IIb/IIIa; MAG, mye-
lin-associated glycoprotein; PL, phospholipid; TPO, thy-
roid per-oxidase; CMV, cytomegalovirus.
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